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Abstract 
 
In response to nutrient limitation, Saccharomyces cerevisiae cells enter into a non-
proliferating state termed quiescence. This transition is associated with profound changes in 
gene expression patterns. The adenine deaminase encoding gene AAH1 is among the most 
precociously and tightly down-regulated gene upon entry into quiescence. We show that 
AAH1 down regulation is not specifically due to glucose exhaustion but is a more general 
response to nutrient limitation. We also found that Aah1p level is tightly correlated to RAS 
activity indicating thus an important role for the proteine kinase A pathway in this regulation 
process. We have isolated three deletion mutants, srb10, srb11 and saf1 (ybr280c) affecting 
AAH1 expression during post-diauxic growth and in early stationary phase. We show that the 
Srb10p cyclin-dependent kinase and its cyclin, Srb11p, regulate AAH1 expression at the 
transcriptional level. By contrast, Saf1p, a previously uncharacterized F-box protein, acts at a 
post-transcriptional level by promoting degradation of Aah1p. This post-transcriptional 
regulation is abolished by mutations affecting the proteasome or constant subunits of the SCF 
(Skp1-Cullin-F-box) complex. We propose that Saf1p targets Aah1p for proteasome-
dependent degradation upon entry into quiescence. This work provides the first direct 
evidence for active degradation of proteins in quiescent yeast cells. 
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Introduction 
 
Most eukaryotic cells spend the majority of their natural lives in a non-proliferating 
state and up to 60% of the biomass on Earth consists of quiescent micro-organisms (Gray et 
al., 2004). Understanding the mechanisms involved in the establishment of stationary phase 
thus appears as a central biological issue. Since cell proliferation results in an increase of the 
biomass, it is strictly conditioned by nutrient availability. Therefore, proliferation of 
unicellular microorganisms, such as the yeast Saccharomyces cerevisiae, tightly reflects 
growth medium richness. When nutrients start to be limiting, yeast cells stop dividing and 
enter into a quiescent state named stationary phase (Gray et al., 2004). Transition from 
proliferation to stationary phase takes a few days and is associated with typical modifications, 
such as accumulation of glycogen and a decrease in cell wall porosity (Werner-Washburne et 
al., 1993). All these changes make yeast cells more resistant to environmental stresses and 
therefore increase their survival probability. Indeed, yeast mutants which are unable to 
properly enter into stationary phase are more sensitive to stress and die precociously under 
starvation conditions (Werner-Washburne et al., 1993). Two major nutrient limitation 
signaling pathways, named RAS and TOR, have been characterized. Defects in these 
pathways either mimic entry into stationary phase even in the presence of nutrients or abolish 
cells capacity to enter properly into quiescence under nutrient limitations (for review see 
(Herman, 2002)).  
Microarray experiments have given an overview of yeast gene expression variations 
associated with entry into quiescence (Gasch et al., 2000; Radonjic et al., 2005). Clearly, 
expression of thousands of genes is affected, with as many genes being up- or down-regulated 
(DeRisi et al., 1997; Gasch et al., 2000). Similarly, during exit from stationary phase, 
expression of multiple genes is affected (Martinez et al., 2004; Radonjic et al., 2005). At the 
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molecular level, Holstege and coworkers found that during stationary phase, RNA polymerase 
II (polII) was poised onto specific promoters corresponding to early activated genes upon 
reentry into proliferation (Radonjic et al., 2005). Interestingly, a link between phosphorylation 
of RNA polII C-terminal domain (CTD), ability to survive in stationary phase and the RAS 
pathway has been reported (Howard et al., 2002). Finally, the Srb10p and Srb11p proteins, 
which are associated to the mediator complex and involved in RNA polII CTD 
phosphorylation, are critical for expression of specific genes and for survival upon starvation 
(Chang et al., 2001; Howard et al., 2002). This suggests that active transcriptional regulation 
is required for proper entry into quiescence. While multiple informations on transcriptional 
processes involved in stationary phase establishment and exit are arising, very little is known 
on post-transcriptional events associated with transition from proliferation to quiescence. In 
fact, protein translation still occurs during stationary phase (Boucherie, 1985; Fuge et al., 
1994) and this process is critical for survival (Choder, 1993). However, despite a growing 
interest on protein degradation, almost nothing is known about this process in the cell 
"quiescence cycle" (entry, maintenance and exit from quiescence).  
AAH1 is an interesting gene model for shedding light on the active molecular 
mechanisms associated with entry and exit from quiescence. AAH1 encodes adenine 
deaminase which converts adenine to hypoxanthine. Microarray data show that AAH1 is one 
of the earliest genes expressed when yeast cells exit from stationary phase (Martinez et al., 
2004; Radonjic et al., 2005), it is also among the most precociously and tightly down-
regulated genes when cells shift from proliferation to quiescence (Gasch et al., 2000). In this 
work, we have isolated three mutants affecting AAH1 expression in early stationary phase. 
Our data show that AAH1  regulation takes place both at transcriptional and post-
transcriptional levels. We show that Srb10p and Srb11p are necessary for proper 
transcriptional regulation of AAH1 while a new F-box protein named Saf1p (Ybr280p) is 
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essential for specific degradation of Aah1p upon nutrient starvation through an SCF- and 
proteasome-dependent mechanism. 
 7 
Results 
 
Adenine deaminase is strongly down regulated in response to nutrient limitation  
Microarray experiments have shown that transcription of the yeast AAH1 gene 
decreased at the diauxic transition (DeRisi et al., 1997). Consistently, we could not detect 
adenine deaminase specific activity in protein crude extracts from post-diauxic wild-type 
yeast cells, while it was estimated at 181 mUnits/mg of protein in extracts from exponentially 
growing cells. This effect was clearly correlated to a lower amount of Aah1p (Fig. 1A) and to 
a decreased of the expression of AAH1 transcript monitored by northern blot (Fig. 1B). The 
decrease of AAH1 expression was the most pronounced upon diauxic shift which corresponds 
to glucose exhaustion (Fig. 1B) while none of the other environmental stresses that we have 
tested had an effect on Aah1p (Fig. 1C). In order to mimic glucose exhaustion, exponentially 
growing cells were transferred to either water or a glucose deprived medium. Clearly, in both 
cases such a brutal starvation did not result in a rapid decrease of Aah1p (Fig. 1D). These data 
strongly suggest that Aah1p regulation is the result of an adaptation process rather than a 
response to starvation stress.  
To elucidate whether Aah1p low expression, when cells enter post-diauxic phase, was 
due to decreased growth rate (increased doubling time) or to nutrient limitation, we first 
modulated cells doubling time under conditions where nutrients are not limiting. This was 
done by growing the cells at different temperatures (22°C and 30°C) or in either poor SD or 
rich SDcasa media. As expected, yeast cells grown in SDcasa medium at 22°C and 30°C had 
very different doubling times (Fig. 2A). We found that the level of Aah1p was slightly lower 
in cells growing at 22°C (about 80% of the amount found in control cells growing at 30°C) 
and that in both cultures, the decrease of Aah1p expression corresponded to the bend of the 
growth curve. Similarly, Aah1p expression was basically the same in cells grown in poor SD 
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and rich SDcasa media (Fig. 2A). We conclude that Aah1p expression is principally down 
regulated in response to nutrient limitation. 
The specificity of the nutrient limitation signal was then estimated by monitoring 
Aah1p steady state levels under conditions where any of the three ingredients of SD medium 
(glucose, ammonium sulfate or yeast nitrogen base) becomes limiting for growth. In all cases, 
nutrient limitation led to an early entry into stationary phase and to a decrease in the 
expression of Aah1p (Fig. 2B). In this experiment, Aah1p expression strongly decreased in 
cultures still containing significant amount of glucose (Fig. 2B lower right panels), thus 
establishing that the decrease in AAH1 expression is not a specific response to carbon 
limitation, but rather a general response to nutrient exhaustion. 
 
Aah1p expression is controled by the RAS cAMP pathway 
RAS and TOR are key pathways regulating stationary phase establishment in response 
to nutrient limitation. We thus evaluated their role in Aah1p down-regulation. We found that 
expression of Aah1p was not strongly affected in a tor1 tor2ts double mutant (Fig. 3A) or in a 
wild-type strain treated with rapamycin, a TOR specific inhibitor (data not shown). 
Furthermore, mutations in several genes involved in the TOR pathway (SIT4, RIM15, RTG1, 
RTG3, MSK1) had no major effect on AAH1 expression (data not shown).  
The expression of Aah1p was then assayed in a RAS2val19 dominant mutant. This 
mutant, because it makes the RAS pathway constitutively active, does not enter stationary 
phase properly (Howard et al., 2002; Toda et al., 1985). Clearly, in a RAS2val19 mutant the 
expression of Aah1p remained high in post-diauxic and stationary phases (Fig. 3B). A similar 
effect, although slightly less pronounced, was found in the BY4742 background using the 
RAS2val19 allele carried on a plasmid (data not shown) and in the W303 background carrying 
the double ira1ira2 knock-out mutations in which the RAS pathway is constitutively activated 
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(Tanaka et al., 1990) (Fig. 3C). On the opposite, in a tpk1w tpk2D tpk3D triple mutant with 
low residual protein kinase A (PKA) activity, Aah1p amount was very low even during 
exponential growth (Fig. 3D). This effect was partially released by a bcy1 mutation, as 
expected since Bcy1p is the PKA regulatory subunit (Fig. 3D). Finally, we found that the 
RAS pathway effect on Aah1p is independent of Msn2p and Msn4p, two transcription factors 
involved in the stress response which are PKA downstream targets. Indeed, the msn2msn4 
double mutant behaved similarly to the wild-type strain in both exponential and stationary 
phases (Fig. 3E). Furthermore, in the msn2msn4 mutant, Aah1p expression was still 
deregulated by the RAS2val19 mutation (Fig. 3E). 
 
SRB10, SRB11 and SAF1 (YBR280c) are required for AAH1 regulation 
To get a better understanding of the molecular mechanisms leading to AAH1  
regulation, we took advantage of an AAH1-lacZ fusion to screen for deregulated mutants 
within a collection of knock-out mutants. In a wild-type strain expressing this AAH1-lacZ 
construct, b-galactosidase activity was strongly regulated by growth phase (Fig. 4A, open 
circles), as expected if the fusion correctly mimics AAH1  expression. The AAH1-lacZ fusion 
was introduced in 75 pools, each containing 60 to 70 individual yeast knock-out mutants, and 
expression of the fusion in the transformants was estimated after 3 days by a colorimetric 
assay. Three mutants allowing higher expression of the fusion were isolated and the mutated 
genes were identified by sequencing the specific tag introduced during gene knock-out 
(Winzeler et al., 1999). The three mutants corresponded to knock-out of the SRB10 and 
SRB11 genes and of the uncharacterized YBR280c open reading frame that we renamed SAF1 
(SCF Associated Factor, see below). We verified that expression of the AAH1-lacZ fusion was 
indeed higher in these mutants during post-diauxic growth (Fig. 4A). This higher bGal 
activity was clearly due to a higher amount of the fusion protein as determined by western 
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blot (Fig. 4B). To ensure that the deregulation of the AAH1-lacZ fusion observed in the 
mutant strains indeed reflects the expression of the endogenous AAH1 gene, steady state 
levels of AAH1 transcript was assayed by northern blot in the wild-type and mutant strains. 
Our results show that the expression of AAH1 is deregulated at the transcriptional level in 
both srb10 and srb11 mutants (Fig. 4C). This was expected, since both genes encode RNA 
PolII-associated factors which have been shown to affect the expression of several genes 
according to growth phase (Chang et al., 2001). Importantly, Srb10p is a cyclin-dependent 
kinase and Srb11p its cognate cyclin. Therefore, isolation of both mutants in the screen was 
highly consistent with an important role of this complex in the transcriptional regulation of 
AAH1. To our surprise, in the saf1 mutant, the AAH1 transcript level decreased just as in the 
wild-type control strain during post-diauxic growth (Fig. 4C), while the amount of Aah1-ßGal 
estimated by western blot was much higher in the saf1 mutant during post-diauxic growth 
(Fig. 4B). We conclude that Srb10p and Srb11p are transcriptional regulators of AAH1 while 
Saf1p most probably acts at a post-transcriptional level.  
 
SAF1 regulates adenine deaminase abundance at a post-transcriptional level 
To establish more precisely the role of SAF1 in AAH1 expression, we expressed AAH1  
under the control of the tet heterologous synthetic promoter which is not affected by growth 
phase (Fig. 5A). Clearly, the amount of Aah1p expressed from the tet promoter fusion was 
still regulated by the growth stage at the protein level (Fig. 5B). Furthermore, Aah1p 
expression driven by the tet promoter was derepressed in the saf1 mutant as expected if Saf1p 
acts at a post-transcriptional level (Fig. 5B). Finally, the effects of srb11 and saf1 mutations 
on AAH1-lacZ expression were clearly additive (Fig. 5C - similar results were obtained with 
srb10 (data not shown)), consistently with the fact that these mutations affect respectively the 
transcriptional and the post-transcriptional regulation of AAH1. 
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Interestingly, Aah1p expressed from the tet promoter was more abundant in post 
diauxic and stationary phases in the RAS2val19 mutant (Fig. 5D). This result is similar to the 
one obtained with the saf1 mutant (Fig. 5B), suggesting that somehow RAS2val19 could 
mimic a saf1 knock-out. Indeed, we observed that in the RAS2val19 mutant, an integrated 
functional Saf1p-13Myc fusion was very poorly expressed compared to wild-type (Fig. 5E). 
This result is in good agreement with previous work by others showing that transcriptional 
expression of SAF1(YBR280c) was repressed by overexpression of RAS2val19 (Wang et al., 
2004). The low expression of Saf1p in the RAS2val19 mutant strain correlated to an increased 
amount of Aah1p, suggesting that under these conditions Saf1p could be limiting for Aah1p 
degradation.  
 
Aah1p degradation in stationary phase is Saf1p dependent 
We then investigated whether the post-transcriptional regulation of Aah1p in 
stationary phase results from a lower translation efficiency or from protein degradation. 
Because the incorporation of [35S] methionine is very low when cells are in stationary phase, 
classical pulse chase experiments were not conclusive. We therefore used a construct in which 
Aah1p was fused to GFP, the two proteins being linked by a TEV protease cleavage site. The 
whole construct was tagged with a myc epitope and was driven by the tet promoter. As 
expected, the fusion protein amount was lower in stationary phase indicating that the fusion 
protein regulation mimics that of the endogenous Aah1p (Fig. 6A). When this fusion was 
coexpressed with the TEV protease placed under the control of a galactose inducible 
promoter, cleavage of the fusion protein could be detected with anti-myc and anti-GFP 
antibodies. We found that, while the GFP half of the cleaved fusion was equally abundant in 
exponential and stationary phase, the myc-Aah1p half was mostly detected in the extract from 
exponentially growing cells. Since both halves result from the same synthesis event, this 
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result demonstrates that the myc-Aah1p half is specifically degraded in stationary phase, 
while the GFP half of the protein is not. Finally, in the saf1 mutant, both halves of the fusion 
protein were equally stable after TEV cleavage (Fig. 6A) clearly establishing that Saf1p is 
required for Aah1p degradation specifically during post-diauxic and stationary phases. Of 
note, we observed that the cleavage of the full- length protein seemed to be slightly more 
efficient in the saf1 mutant than in the wild-type strain. One explanation could be that Saf1p 
might affect the cleavage process through an interaction with the fusion protein. 
Why should Aah1p be actively degraded upon transition from proliferation to 
quiescence? One possibility could be that during quiescence, Aah1p becomes misfolded and 
targeted for degradation. This issue was addressed by directly measuring adenine deaminase 
in a saf1 mutant unable to degrade Aah1p. Results presented in figure 6B clearly show a good 
correlation between Aah1p amount determined by western blot and adenine deaminase 
activity. We then conclude that during post-diauxic growth Saf1p participates to degradation 
of enzymatically active adenine deaminase. 
 
Degradation of Aah1p is abolished in SCF and proteasome mutants  
 Although the function of Saf1p is not known, it is one of the 21 yeast proteins 
containing an F-box motif (Willems et al., 2004). Such proteins were shown to recruit specific 
substrates to the SCF (Skp1-Cullin-F-box) complex and consequently target them for 
degradation by the proteasome (Hershko and Ciechanover, 1992). We therefore asked 
whether mutants affecting ubiquitin-conjugating enzyme (Cdc34p), SCF (Cdc53p, Skp1p, 
Hrt1p) or proteasome (Cim5p) subunits would abolish Aah1p degradation during quiescence. 
Indeed, in stationary phase, Aah1p was much more abundant in the hrt1 mutant 
(affected in the RING finger SCF-component) than in the wild-type strain (Fig. 7A). 
Similarly, Aah1p was stabilized in skp1-12 and cdc34-2 mutants during post-diauxic growth 
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and somewhat intermediary in the cdc53-1 mutant (Fig. 7B) possibly because this mutant 
grows poorly and tends to revert rapidly. The amount of Aah1p was clearly not affected in the 
F-box cdc4-1 mutant (Fig. 7B) neither by mutations in 14 other F-box encoding yeast genes 
(MET30, GRR1, YDR131c, YDR219c, YDR306c, YJL149w, YJL204c, YLR097c, YLR224w, 
YLR368w, YML088w, YNL230c, YNL311c, YOR080w) (data not shown). These results show 
that the regulatory role of Saf1p is Hrt1p-, Skp1p- and Cdc34p-dependent but is independent 
of the non-constant SCF F-box subunits.  
The role of the proteasome in Aah1p regula tion was then evaluated using a cim5-1 
temperature sensitive mutant affecting the proteasome function. CIM5 (RPT1) encodes an 
ATPase component of the 26S proteasome complex. Our results show that Aah1p was much 
more abundant in the cim5-1 mutant than in the wild-type in stationary phase (Fig. 7C). 
Together these results establish that both the SCF and the proteasome are required for proper 
post-transcriptional regulation of Aah1p. 
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Discussion 
 
We found that yeast adenine deaminase synthesis is regulated both at transcriptional 
and post-transcriptional levels. This dual regulation could account for the discrepancies 
between our results (Fig. 1C) and microarray data (Gasch et al., 2000) in response to stresses. 
Indeed, AAH1 transcript level was strongly affected by various environmental stresses while 
we found no effect at the protein level. The fact that down regulation of AAH1 in response to 
nutrient limitation takes several hours indicates that it is the result of a slow adaptative 
process to nutrient exhaustion rather than an instantaneous response to starvation or stress. 
Why should Aah1p be degraded during quiescence? Our data do not support a model 
in which Aah1p would become misfolded but rather argue for the fact that Aah1p amount 
should be strictly controlled during establishment of- and/or exit from quiescence. Indeed, 
AAH1 is one of the most precociously transcribed genes when yeast cells exit from stationary 
phase (Martinez et al., 2004). However, we found that the lack of Aah1p degradation in a saf1 
mutant does not affect entry or survival in stationary phase (S. E., J. C. and B. D.-F. 
unpublished data) and the relationship between Aah1p expression and quiescence remains 
puzzling. At this point, we cannot formally exclude that Aah1p could have an additional 
cellular function distinct from its adenine deaminase activity although there is no 
phenotypical evidence for such a role. Alternatively, it could be that guanylic nucleotides 
synthesis should decrease to allow proper entry into stationary phase, as shown in the bacteria 
Bacillus subtilis (Ratnayake-Lecamwasam et al., 2001). This possibility is further supported 
by the fact that all yeast GMP biosynthesis genes are regulated by nutrient availability at the 
transcriptional level (Escobar-Henriques et al., 2003). However, none of the other purine 
salvage enzymes tested (Amd1p, Apt1p, Gua1p, Hpt1p, Imd2p) appear to be regulated at the 
post-transcriptional level (S. E. and B. D.-F. unpublished data). Importantly, although AAH1  
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and IMD2 are both tightly regulated in response to nutrient limitation (Fig. 1B, (Escobar-
Henriques et al., 2003)) neither srb10, srb11 or saf1 mutations have an effect on IMD2-lacZ 
expression (J. C. and B. D.-F. unpublished data), indicating that similar regulations occur 
through different means. However it is noteworthy that Srb10p and Srb11p were found 
critical for transcriptional down-regulation of the ACT1 gene in stationary phase (Chang et al., 
2001). Our results with AAH1 further substantiate the role of Srb10p and Srb11p in 
transcriptional regulation upon post-diauxic and stationary phases. According to recent 
results, RNA polymerase II is maintained upstream of many stationary phase repressed genes 
(Radonjic  et al., 2005). It is thus tempting to speculate that Srb10p and Srb11p could 
contribute to this phenomenon. Although, the metabolic signal that triggers Aah1p 
degradation is not identified yet, we have shown that the RAS pathway plays an important 
role in the down-regulation of AAH1. Our data (Fig. 5E) show that a constitutively active 
RAS pathway results in a low Saf1p steady state level correlated to an increased amount of 
Aah1p. These data provide a simple and attractive explanation for the high level of Aah1p 
observed in the RAS2val19 mutant. However, we cannot rule out that part of the effect of the 
RAS pathway on AAH1 expression could be Saf1p- independent. 
 
The transition from proliferation to quiescence is associated to changes in the 
proteome composition (Werner-Washburne  et al., 1996). This implies that new specific 
proteins are synthesized while others disappear. Since quiescent cells do not divide and 
considering the long half- life of peptide bonds (Kahne D, 1988), disappearance of proteins 
cannot result from passive dilution but is necessarily the result of an active degradation 
process. This process could be dependent on the ubiquitin proteasome system since a major 
role for ubiquitin in stationary phase has already been suggested by the fact that ubiquitin is 
required for survival during starvation (Finley et al., 1987; Swaminathan et al., 1999). In this 
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work we have established that Aah1p degradation is Saf1p-, SCF- and proteasome-dependent. 
Saf1p was shown to interact with Aah1p ((Ho et al., 2002), our unpublished data) and to 
immunoprecipitate with Skp1p and Cdc53p (Seol et al., 2001), two constant subunits of S. 
cerevisiae SCF. Thus, as shown for other F-Box proteins, Saf1p could link its target (Aah1p) 
to the SCF core subunits. We therefore propose that Saf1p could participate to a new SCF 
complex specifically targeting Aah1p for proteasome-dependent degradation during the yeast 
quiescent cycle. 
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Materials and methods  
 
Strains and media 
Yeast strains used in this study are described in Table I. Yeast cells were grown in YPD (1% 
yeast extract, 2% peptone, and 2% glucose) or in synthetic medium (0.17% nitrogen base, 
0.5% ammonium, and 2% of either glucose (SD), raffinose or galactose). SDcasaWA is SD 
medium supplemented with 0.2% (w/v) casaminoacids (Difco), tryptophan (40 mg/L) and  
adenine (40 mg/L). Histidine (10 mg/L), lysine (10 mg/L), uracil (20 mg/L), and methionine 
(20 mg/L) were added when necessary.  
 
DNA manipulations 
To express the AAH1 gene under control of a repressible tetracycline promoter (tet), AAH1 
coding sequence was amplified by PCR using oligonucleotides 531 (5'-CGC GGA TCC ATA 
ATG GTT TCT GTG GAG TTT-3') and 532 (5'-CCA ATG CAT CTA ATG CGA ATA TTT 
AGT GAC-3'). This PCR fragment digested with BamHI and NsiI was cloned in pCM189 
(Gari et al., 1997) opened with BamHI and PstI. The resulting plasmid was named p2088. 
AAH1-lacZ fusion (p1459) was constructed by PCR amplification of AAH1 with 
oligonucleotides 276 (5'-CAG CAT CTC CAG AGC ATG-3') and 277 (5'-ACG CGT CGA 
CCA TGC GAA TAT TTA GTG ACT AC-3'), followed by digestion with HpaI-SalI and 
cloned at SmaI-SalI sites in YEp356 (Myers et al., 1986). The tet-mycAAH1-tev-GFP plasmid 
was constructed as follows. AAH1 was PCR amplified using oligonucleotides 276 and 277 
(see above), the PCR product was cloned after restriction with HpaI-SalI in SmaI-SalI sites of 
p1257, containing the GFP-coding sequence. The resulting plasmid was named p1384. A 
TEV cleavage site between AAH1 and GFP was introduced using two complementary 
oligonucleotides containing the TEV cleavage site sequence (5'-TCG AGC TTC TGC TTC 
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TGA AAA TTT GTA TTT TCA AGG-3' and 5'-TCG ACC TTG AAA ATA CAA ATT TTC 
AGA AGC AGA AGC-3') ligated at the unique SalI site of p1384. The resulting plasmid was 
named p2767. An AAH1-tev-GFP fragment obtained by PCR amplification on p2767 with 
oligonucleotides 531 (see above) and 1118 (5'- CCA ATG CAT TAT TTG TAC AAT TCA 
TCC ATA CC-3') was digested by BamHI-NsiI and cloned at BamHI-PstI sites of p2717 (a 
derivative of pCM189 in which a myc tag has been introduced downstream of the tet 
promoter). 
PGal TEV (pYEF1-T TEV-HA) (Sagot et al., 1999) was used to express TEV protease in 
yeast under control of a galactose inducible (GAL) promoter; pYEF1-T was used as control 
vector. The URA3 CEN pRAS2val19 is a kind gift from Dr. M Wigler. 
Strain expressing a 13myc epitope-tagged version of Saf1p at the SAF1 locus (Y2685) was 
constructed as follows: a 13myc-His3MX6 cassette was amplified by PCR using pFA6a-
13myc-His3MX6 (Longtine  et al., 1998) as a template with primers containing SAF1-specific 
sequences: 1176 (5'-ACGGAATCCAAAATGCAAAATCGAAATGACACCTAAAAAT 
GAA TTC GAG CTC GTT TAA AC-3') and 1177 (5'-T GGT 
GGCTGGCAAACCGGTGCATTAATCATCAAG AAG CAT CGG ATC CCC GGG TTA 
ATT AA-3'). The PCR product was transformed into a wild type strain (BY4741) and 
transformants were selected on medium lacking histidine. Correct integration of the module 
by homologous recombination at the SAF1 locus was verified by PCR. 
 
Western blot analyzes  
Strains were grown overnight in appropriate medium and then diluted at OD600=0.1. 
Typically, cells were harvested at several times during growth: exponential growth (8 hours), 
post-diauxic stage (24 hours) and early stationary phase (48 hours) (however, we are fully 
aware that entry in stationary phase is a continuum rather the succession of discrete steps). 
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For each growth stage, an equivalent quantity of cells was removed (6.107 cells). Collected 
cells were disrupted with glass beads in 500 mL of TCA 5%. Samples were centrifuged 
(16,000 g during 5 min) and proteins were resuspended in 50 mL of SDS-PAGE sample buffer 
(125 mM Tris/HCl pH 6.8, 5% SDS, 50% glycerol, 2% b-mercaptoethanol). Extracts were 
boiled for 5 min and 10 mL were loaded onto a 12.5% SDS-PAGE gel. After electro-transfer, 
PVDF membranes were incubated with a 1:10,000 dilution of monoclonal mouse anti-myc 
antibodies (9E10; Covance), or a 1:15,000 dilution of polyclonal rabbit antibodies raised 
against the N-term part (from amino acyl 1 to 177) of Aah1p, or a 1:30,000 dilution of 
polyclonal rabbit antibodies raised against Ade13p (full- length), or a 1:25,000 dilution of 
polyclonal antibodies anti-GFP (Santa Cruz Biotechnology) or 1:10,000 dilution of polyclonal 
antibodies anti-bGalactosidase (Rockland) or 1:25,000 dilution of polyclonal antibodies anti-
Act1p gracefully given by Dr. JA Cooper (Washington University School of Medicine, St. 
Louis, MO). Primary antibodies were detected with horseradish peroxidase-conjugated anti-
rabbit or anti-mouse secondary antibodies followed by chemiluminescence.  
 
Screen for deregulated mutants for AAH1 expression  
A collection of 4767 haploids yeast knock-out mutants (purchased from EUROSCARF) was 
screened for mutants with altered expression of the bifunctional AAH1-lacZ fusion reporter. 
Using a colometric assay (X-gal), we could discriminate after 2 or 3 days, colonies with high 
b-gal activity (deep blue) of those with low activity (light blue). Mutant strains distributed in 
75 micro-plates of 60 to 70 individual strains were grown for 2 days on YPD medium. Strains 
from each plate were pooled and transformed with plasmid p1459 expressing the AAH1-lacZ 
fusion. Transformants were replicated on two plates of SDcasaWA solid medium. One plate 
was conserved and the other was tested for b-gal activity by "agar-overlay" after 3 days at 
30°C : 1 mL of chloroform was added on plate and then 10.2 mL of a solution containing 5 ml 
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agarose 1%, 5 ml KPi 1M pH 7, 100 mL SDS 10% (w/v) and 100 mL 5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside (X-gal) solubilized in N-N-dimethyl formamide. b-gal activity 
of colonies was estimated by their capacity to degrade X-gal, leading to a blue color. 35 
strains were selected for a deep blue coloration after 3 days. 32 false positive candidates were 
eliminated. Then, we identified the mutated gene in the 3 remaining mutants by sequencing 
the deletion cassette KanMX4 which contains a specific sequence tag (Winzeler et al., 1999). 
These three mutations corresponded to the knock-out of SRB10 and SRB11 genes, and 
YBR280c an open reading frame of unknown function that we renamed SAF1. 
 
Glucose assay 
Glucose concentration was determined by using the glucose assay kit (ref GAGO-20) (Sigma, 
Saint Louis, MI) or the "D-glucose/D-fructose" kit (ref. 10139106035, Roche) 
 
Northern blot analyzes 
Yeast strains were grown in the same conditions as for western blot analysis. Total RNAs 
were isolated using the TRI-Reagent RNA/DNA/Protein isolation reagent kit 
(EUROMEDEX). RNA blots were prepared as described previously (Denis  et al., 1998) and 
probed with a PCR fragment specific for the AAH1 gene, amplified from S288C genomic 
DNA template. After autoradiography, the bound probe was removed from the membrane (by 
treatment with a 0.1% SDS boiling solution) and then probed again with PDA1 gene as a 
loading control. PDA1 was used because its expression was only slightly affected during 
stationary phase (Wenzel et al., 1995).  
 
b-Galactosidase assays 
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Cells grown in selective medium for the reporter plasmid (p1459) were collected at several 
times to assess the expression of AAH1-lacZ during growth. b-Galactosidase assays were 
performed as described (Kippert, 1995). b-Galactosidase units are defined as (A420 x 
1000)/(A600 x min x mL). 
 
Adenine deaminase assay 
Adenine deaminase activity in protein extracts were measured using a spectrophotometric 
assay based on a coupled reaction with xanthine oxydase. Hypoxanthine produced from 
adenine by Aah1p could be followed by a two-step transformation into uric acid by adding 
commercial xanthine oxydase (Roche). Uric acid appearance was monitored by its specific 
absorbance at 293 nm. Cells were then washed with water, resuspended in 0.6 mL breaking 
buffer (20 mM Tris/HCl pH 7.9, 1 mM EDTA, 5% glycerol, 1 mM dithiotreitol, and 2 mM 
phenylmethylsulfonylfluoride) and then broken with glass beads by vortexing 3 times 30 
seconds. After centrifugation (5 min at 16,000 g), 10 mL of the supernatant were used for 
enzymatic assay. Reaction was carried out in potassium phosphate buffer 100 mM pH 7.5, 
adenine 6 mM, and 0.16 unit of xanthine oxydase. Absorbance was monitored at 293 nm 
during 10 min. Protein concentration was determined using the Bio-Rad (Hercules, CA)  
Protein Micro Assay system with bovine serum albumin as reference standard. 
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Fig. 1. The level of Aah1p decreases in early stationary phase but not in response to 
environmental stresses.  
A. Growth curve of wild-type yeast strain BY4742 grown in SDcasaWA medium (OD 600: 
optical density at 600 nm). Aliquots were removed at indicated times (dotted lines) and 
proteins extracts were analyzed by western blot with polyclonal antibodies against Aah1p and 
Ade13p (as a loading control). 
B. Aliquots of wild type BY4742 strain (open circles) were harvested at indicated times 
(dotted lines). Total RNAs were extracted and expression of AAH1 and PDA1 (as a loading 
control) was analyzed by Northern blot. At each time point, glucose concentration in the 
medium was determined (closed squares). 
C. Wild-type yeast strain BY4242 was grown in YPDA rich medium to mid- log phase. Cells 
were shifted at time 0 in the same medium supplemented or not (control) with hydrogen 
peroxide (0.4 mM), ethanol (7.5%), NaCl (0.3 M), or sorbitol (0.4 M). For the "heat shock" 
conditions, cells were grown in YPDA rich medium at 25°C to mid- log phase and shifted at 
37°C (time 0). Samples were collected at indicated times and were analyzed by western blot 
with polyclonal antibodies against Aah1p. 
D. Wild type strain was grown in SDcasaWAU medium to mid log phase and was shifted at 
time 0 in water (H20) or in the same medium deprived of glucose. Samples were collected at 
indicated times and analyzed as in C. 
 
Fig. 2. Aah1p is down regulated in response to nutrient limitation. 
A. Growth curves of a prototrophic wild-type strain FY4 grown in SDcasa at 30°C (crosses), 
or in SDcasa at 22°C (circles) or in SD at 30°C (diamonds) are represented. The doubling 
time of the strain under these conditions is respectively 100, 125 and 162 min. Samples were 
collected at 3 time points corresponding to the intersection between each growth curve and 
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the dotted lines (1: exponential growth, E; 2: post-diauxic phase, PD; and 3: stationary phase, 
S) and proteins extracts were analyzed by western blot with polyclonal antibodies against 
Aah1p and Ade13p. 
B. Wild-type strain FY4 was grown in regular SD medium (diamonds) or in the same medium 
containing a limiting amount of one of the three SD components (squares: 0.2% glucose, 
triangles: 0.05% ammonium sulphate (AS), crosses: 0.1x Yeast Nitrogen Base). Aliquots were 
collected and analyzed as in A. Glucose concentration was assayed for the 3 time points. nd 
stands for not detectable. 
 
Fig. 3. The RAS cAMP pathway controls Aah1p expression. 
A. Wild-type (JK9-3da) and tor1Dtor2-21 (SH221) double mutant strains were grown at 30°C 
in SDcasaWAU medium and samples were collected during exponential (E), post-diauxic 
(PD) and stationary (S) phases. Cells were then shifted at 37°C during 1 hour. Proteins were 
extracted and analyzed by western blot with anti-Aah1p and anti-Ade13p antibodies. 
B. Wild-type (SP1) strain and RAS2val19 (SP1Ras2val19) dominant mutant were grown in 
SDcasaWAU medium. Cells were harvested during exponential (E), post-diauxic (PD) and 
stationary (S) phases and were analyzed by western blot with antibodies against Aah1p and 
Ade13p. 
C. The double ira1ira2 double mutant and wild-type strain (W303-1A) were analyzed as in B. 
D. Wild-type (SP1) strain, tpk1wtpk2Dtpk3D (S18-1D) triple mutant and bcy1Dtpk1wtpk2D 
tpk3D (CY800) quadruple mutant were grown in SDcasaWAU at 30°C and cells were 
collected during exponential (E) and stationary (S) phases. Proteins extracts were analyzed as 
in B. 
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E. Wild type (W303-1A) and msn2Dmsn4D  (Wmsn2msn4) double mutant strains were 
transformed with plasmid expressing RAS2val19 allele or with the empty vector as control. 
Cells were grown in SDcasaWA medium and were treated as in B.  
 
Fig. 4. Isolation of mutants deregulated for Aah1p-bGalactosidase expression. 
A. Growth curves of the wild type, srb10D, srb11D, and saf1D yeast strains transformed with 
AAH1-lacZ plasmid (upper panel) and respective ß-galactosidase (ßGal) activity 
measurements (lower panel). 
B and C. Samples of each culture were harvested at 2 time points (1: exponential phase and 2: 
post-diauxic phase as annotated in growth curve (see A)). For each samples, proteins or total 
RNAs were extracted. Protein extracts were analyzed by Western blot with polyclonal 
antibodies against b-galactosidase and Ade13p (B) and total RNAs extracts were analyzed by 
Northern blot with an AAH1 specific probe (C); rRNA 18S and 28S were used as loading 
controls.  
 
Fig. 5. Saf1p acts at a post-transcriptional level.  
A. Total RNAs of wild-type strain BY4742 transformed with plasmid expressing AAH1  under 
the control of a tetracycline repressible promoter (tet-AAH1) were analyzed at exponential 
(E), post-diauxic (PD) and stationary (S) phases by northern blot with specific probes for 
AAH1 and PDA1 (as a loading control). 
B. Wild-type and saf1D strains carrying the tet-AAH1 plasmid were collected at exponential 
(E), post-diauxic (PD) and stationary (S) phases and protein extracts were analyzed by 
western blot with polyclonal antibodies against Aah1p and Ade13p. 
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C. Wild-type, srb11D, saf1D, srb11Dsaf1D yeast strains were transformed with the AAH1-
lacZ plasmid. Aliquots were taken at various time points and assayed for b-galactosidase 
activity. 
D. Wild-type strain (Y2446) was co-transformed with tet-AAH1 and either an empty vector 
(control) or RAS2val19 plasmid. Cells were collected at exponential (E), post-diauxic (PD). 
E. A strain expressing a 13 myc epitope-tagged version of Saf1p at the SAF1 locus (Y2685) 
and transformed with plasmid expressing RAS2val19 allele (or with the empty vector as 
control) were grown in SDcasaWA medium. Samples were collected and analyzed as in B 
with anti-myc epitope, anti-Aah1p, and anti-Act1p antibodies (as loading control) 
 
Fig. 6. Aah1p is degraded through a Saf1p dependent mechanism.  
A. Wild type (Y2445) and Dsaf1 (Y2447) yeast strains were co-transformed with two 
plasmids. The first plasmid allows the expression of Aah1p (tagged on N-term extremity with 
a myc epitope) fused to GFP on C-term (p2774), the two proteins being separated by a TEV 
endoproteolytic cleavage site (see schematic representation on the left). The second expresses 
or not (empty control plasmid, pGal) the TEV protease under control of a galactose inducible 
promoter (pGal TEV). Strains were grown in 2% galactose synthetic medium and harvested 
during exponential (E), post diauxic (PD) and stationary (S) phases. Protein extracts were 
analyzed by western blot with polyclonal antibodies against GFP and Ade13p (as loading 
control) and monoclonal antibodies against the myc epitope. 
B. Total protein extracts of wild type BY4741 and Dsaf1 strains were assayed for adenine 
deaminase activity; in exponential phase (deep grey) and in stationary phase (light grey). 
Protein from the same extracts were also analyzed by western blot and Aah1p amount was 
quantified (lower panel); 100% refers to the amount of Aah1p in the wild type strain in 
exponential phase. nd stands for not detectable. 
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Fig. 7. Aah1p degradation requires proteasome and SCF core subunits.  
A. Wild-type and hrt1-m27 yeast strains were transformed with a plasmid expressing AAH1  
under the control of the tet promoter and grown at 25°C. Aliquots were removed during 
exponential (E) and stationary (S) phases and proteins extracts were analyzed by western blot 
with antibodies against Aah1p and Ade13p.  
B. Wild-type (W303), Daah1, Dsaf1, skp1-12, cdc4-1, cdc34-2 yeast strains transformed with 
the tet-AAH1 plasmid were grown at 25°C during 2 days and were shifted to 37°C during 1 
hour. Extracts were then analyzed as in A.  
C. Wild type and isogenic cim5-1 mutant strains were transformed with a plasmid expressing 
AAH1 under the tet promoter. Cells were grown in SDcasaWA medium at permissive 
temperature (25°C), to exponential (E) and stationary (S) phases. Cells were then shifted at 
restrictive temperature (37°C) for 1 hour before protein extraction. Protein extracts were 
immunoblotted with antibodies against Aah1p and Ade13p. 
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TABLE I.  S. cerevisiae strains used in this study 
Name Genotype Source 
BY4741 MATa, his3D1, leu2D0, met15D0, ura3D0 (Brachmann et al., 1998) 
BY4742 MATa, his3 D1, leu2D0, lys2 D0, ura3D0 (Brachmann et al., 1998) 
FY4 MATa, GAL2  (Winston et al., 1995) 
SP1 MATa, leu2, ura3, trp1, his3, ade8, can1 (Toda et al., 1985) 
TK16-R2V MATa, leu2, ura3, trp1, his3, ade8, can1, RAS2val19  (Toda et al., 1985) 
Y12786 MATa, his3 D1, leu2D0, lys2 D0, ura3D0, srb10::KANMX4 EUROSCARF 
Y15351 MATa, his3 D1, leu2D0, lys2 D0, ura3D0, srb11::KANMX4 EUROSCARF 
Y17172 MATa, his3 D1, leu2D0, lys2 D0, ura3D0, saf1::KANMX4 EUROSCARF 
Y12935 MATa, his3 D1, leu2D0, lys2 D0, ura3D0, aah1::KANMX4 EUROSCARF 
Y1664 MATa, his3 D1, leu2D0, lys2 D0, ura3D0, saf1::KANMX4, srb11::KANMX4 this study 
Y2445 MATa, his3 D1, leu2D0, lys2 D0, ura3D0, trp1::HIS3 this study 
Y2447 MATa, his3 D1, leu2D0, lys2 D0, ura3D0, saf1::KANMX4, trp1::HIS3 this study 
Y2685 MATa, his3 D1; leu2D0; lys2D0; ura3D0, SAF1-13myc-HIS3MX6 This study 
SH221 MATa,leu2-3,112 ura3 rme1 trp1 his3 ade2D tor1::HIS3-3  
tor2::ADE2-3 / YCplac111::tor2-21ts 
(Helliwell et al., 1998) 
JK9-3da MATa leu2-3, 112 trp1 ura3 rme1 his4  (Helliwell et al., 1998) 
SP1 MATa ade8 his3 leu2 ura3 trp1 can1 M Wigler  
SP1Ras2val19 MATa ade8 his3 leu2 ura3 trp1 can1 RAS2val19 M Wigler  
ira1ira2 MATa ade2 can1 his3 leu2 trp1 ura3 ira1::LEU2 ira2::URA3 (Tanaka et al., 1990) 
Wmsn2msn4 MATa ade2 can1 his3 leu2 trp1 ura3 msn4::TRP1 msn2::HIS3 (Gorner et al., 1998) 
S18-1D MATa ade8 ura3 his3 leu2 trp1 tpk1w1 tpk2::HIS3 tpk3::TRP1  (Nikawa et al., 1987) 
CY800 MATa ade8 can1 his3 leu2 trp1 ura3 tpk1w tpk2::HIS3 tpk3::TRP1 bcy1::LEU2 (Nikawa et al., 1987) 
m27-15b hrt1-m27, gic2::LEU2, his3 -11::GAL-Gic2-HIS3, ade2-1, trp1-1, can1-100 , leu2-
3,112 , his3 -11,15, ura3, gal-, psi+, ssd1-d2 
(Blondel et al., 2000) 
MJ212 ts, cdc53-1, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL+ (Jaquenoud et al., 1998) 
ES197 ts, cdc4-1, ade2-11, trp1-1, can1-100, leu2-3,112, his3-11, 15, ura3, GAL+, psi (Schwob et al., 1994) 
ES460 ts, cdc34-2, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL+ (Schwob et al., 1994) 
Y554 ts, skp1-12, ade2-1, trp1-1, can1-100 , leu2-3,112 , his3 -11,15, ura3, GAL+ (Bai et al., 1996) 
W303 ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL+, psi+, ssd1-d2 (Thomas and Rothstein, 1989) 
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